Revenues of the company rose in both the verticals of Formulations and Active Pharmaceutical Ingredients (Apls), Ipca Laboratories said. The revenues from Formulations rose to Rs 580.31 crore in the Q1 of FY14 as against Rs 448.69 crore for the same period last fiscal. The revenues from APls also rose to Rs 212.22 crore in the first quarter of FY'14 as against Rs 181.56 crore in the year ago period, it added.
Ipca Laboratories has a strong thrust on exports which now account for nearly 61 per cent of its income, the company said. Shares of Ipca Laboratories were today trading at Rs 656.10 apiece in the afternoon trade on BSE, up 1.45 per cent from their previous close.